{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:38:31Z","timestamp":1773797911517,"version":"3.50.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-025-01372-z","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:10:44Z","timestamp":1773767444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Colorectal Micropapillary Adenocarcinoma: Molecular Mechanisms and Clinical Implications"],"prefix":"10.1007","volume":"57","author":[{"given":"Baijian","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingsong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"5","key":"1372_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2559.2005.02241.x","volume":"47","author":"K Sakamoto","year":"2005","unstructured":"Sakamoto K, Watanabe M, De La Cruz C, et al. Primary invasive micropapillary carcinoma of the colon. Histopathology. 2005;47(5):479\u201384. https:\/\/doi.org\/10.1111\/j.1365-2559.2005.02241.x.","journal-title":"Histopathology"},{"issue":"16","key":"1372_CR2","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.3748\/wjg.v20.i16.4597","volume":"20","author":"K Guzi\u0144ska-Ustymowicz","year":"2014","unstructured":"Guzi\u0144ska-Ustymowicz K, Niewiarowska K, Pryczynicz A. Invasive micropapillary carcinoma: a distinct type of adenocarcinomas in the gastrointestinal tract. World J Gastroenterol. 2014;20(16):4597\u2013606. https:\/\/doi.org\/10.3748\/wjg.v20.i16.4597.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"1372_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11071036","volume":"11","author":"A Remo","year":"2019","unstructured":"Remo A, Fassan M, Vanoli A, et al. Morphology and molecular features of rare colorectal carcinoma histotypes. Cancers (Basel). 2019;11(7):1036. https:\/\/doi.org\/10.3390\/cancers11071036.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"1372_CR4","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/modpathol.2012.163","volume":"26","author":"HJ Lee","year":"2013","unstructured":"Lee HJ, Eom DW, Kang GH, et al. Colorectal micropapillary carcinomas are associated with poor prognosis and enriched in markers of stem cells. Mod Pathol. 2013;26(8):1123\u201331. https:\/\/doi.org\/10.1038\/modpathol.2012.163.","journal-title":"Mod Pathol"},{"issue":"2","key":"1372_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics [published correction appears in CA Cancer J Clin. 2011 Mar-Apr;61(2):134 ]. CA Cancer J Clin. 2011;61(2):69\u201390. https:\/\/doi.org\/10.3322\/caac.20107.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"1372_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11888-015-0280-7","volume":"11","author":"ID Nagtegaal","year":"2015","unstructured":"Nagtegaal ID, Hugen N. The increasing relevance of tumour histology in determining oncological outcomes in colorectal cancer. Curr Colorectal Cancer Rep. 2015;11(5):259\u201366. https:\/\/doi.org\/10.1007\/s11888-015-0280-7.","journal-title":"Curr Colorectal Cancer Rep"},{"issue":"6","key":"1372_CR7","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1053\/j.gastro.2009.12.065","volume":"138","author":"MS Pino","year":"2010","unstructured":"Pino MS, Chung DC. The chromosomal instability pathway in colon cancer. Gastroenterology. 2010;138(6):2059\u201372. https:\/\/doi.org\/10.1053\/j.gastro.2009.12.065.","journal-title":"Gastroenterology"},{"issue":"5","key":"1372_CR8","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.21873\/anticanres.12539","volume":"38","author":"M Patankar","year":"2018","unstructured":"Patankar M, V\u00e4yrynen S, Tuomisto A, M\u00e4kinen M, Eskelinen S, Karttunen TJ. Micropapillary structures in colorectal cancer: an anoikis-resistant subpopulation. Anticancer Res. 2018;38(5):2915\u201321. https:\/\/doi.org\/10.21873\/anticanres.12539.","journal-title":"Anticancer Res"},{"key":"1372_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102070","volume":"89","author":"D Uprety","year":"2020","unstructured":"Uprety D, Adjei AA. KRAS: from undruggable to a druggable cancer target. Cancer Treat Rev. 2020;89:102070. https:\/\/doi.org\/10.1016\/j.ctrv.2020.102070.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"1372_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01441-4","volume":"20","author":"G Zhu","year":"2021","unstructured":"Zhu G, Pei L, Xia H, Tang Q, Bi F. Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer. Mol Cancer. 2021;20(1):143. https:\/\/doi.org\/10.1186\/s12943-021-01441-4.","journal-title":"Mol Cancer"},{"issue":"7","key":"1372_CR11","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1200\/JCO.2009.24.6116","volume":"28","author":"A Bardelli","year":"2010","unstructured":"Bardelli A, Siena S. Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer. J Clin Oncol. 2010;28(7):1254\u201361. https:\/\/doi.org\/10.1200\/JCO.2009.24.6116.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1372_CR12","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.7314\/apjcp.2016.17.3.1175","volume":"17","author":"O Gorukmez","year":"2016","unstructured":"Gorukmez O, Yakut T, Gorukmez O, Sag SO, Karkucak M, Kanat O. Distribution of KRAS and BRAF mutations in metastatic colorectal cancers in Turkish patients. Asian Pac J Cancer Prev. 2016;17(3):1175\u20139. https:\/\/doi.org\/10.7314\/apjcp.2016.17.3.1175.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"1372_CR13","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.7150\/ijbs.88779","volume":"20","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Kuang Y, Wang C, Yu Y, Pan L, Hu X. Impact of KRAS mutation on the tumor microenvironment in colorectal cancer. Int J Biol Sci. 2024;20(5):1947\u201364. https:\/\/doi.org\/10.7150\/ijbs.88779.","journal-title":"Int J Biol Sci"},{"key":"1372_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev-med-080819-033145","volume":"72","author":"KZ Thein","year":"2021","unstructured":"Thein KZ, Biter AB, Hong DS. Therapeutics targeting mutant KRAS. Annu Rev Med. 2021;72:349\u201364. https:\/\/doi.org\/10.1146\/annurev-med-080819-033145.","journal-title":"Annu Rev Med"},{"issue":"10","key":"1372_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.trecan.2017.08.006","volume":"3","author":"KM Haigis","year":"2017","unstructured":"Haigis KM. KRAS alleles: the devil is in the detail. Trends Cancer. 2017;3(10):686\u201397. https:\/\/doi.org\/10.1016\/j.trecan.2017.08.006.","journal-title":"Trends Cancer"},{"issue":"4","key":"1372_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ccell.2020.03.013","volume":"37","author":"M Drosten","year":"2020","unstructured":"Drosten M, Barbacid M. Targeting the MAPK pathway in KRAS-driven tumors. Cancer Cell. 2020;37(4):543\u201350. https:\/\/doi.org\/10.1016\/j.ccell.2020.03.013.","journal-title":"Cancer Cell"},{"issue":"11","key":"1372_CR17","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.7150\/thno.73089","volume":"12","author":"W Chong","year":"2022","unstructured":"Chong W, Zhu X, Ren H, et al. Integrated multi-omics characterization of KRAS mutant colorectal cancer. Theranostics. 2022;12(11):5138\u201354. https:\/\/doi.org\/10.7150\/thno.73089.","journal-title":"Theranostics"},{"issue":"7","key":"1372_CR18","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC. AKT\/PKB signaling: navigating downstream. Cell. 2007;129(7):1261\u201374. https:\/\/doi.org\/10.1016\/j.cell.2007.06.009.","journal-title":"Cell"},{"issue":"9","key":"1372_CR19","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1093\/annonc\/mdw261","volume":"27","author":"DP Modest","year":"2016","unstructured":"Modest DP, Ricard I, Heinemann V, et al. Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group. Ann Oncol. 2016;27(9):1746\u201353. https:\/\/doi.org\/10.1093\/annonc\/mdw261.","journal-title":"Ann Oncol"},{"issue":"8","key":"1372_CR20","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1158\/1541-7786.MCR-21-0994","volume":"20","author":"SH Choi","year":"2022","unstructured":"Choi SH, Kim JK, Chen CT, et al. KRAS mutants upregulate integrin \u03b24 to promote invasion and metastasis in colorectal cancer. Mol Cancer Res. 2022;20(8):1305\u201319. https:\/\/doi.org\/10.1158\/1541-7786.MCR-21-0994.","journal-title":"Mol Cancer Res"},{"issue":"11","key":"1372_CR21","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/annonc\/mdx401","volume":"28","author":"E Sanz-Garcia","year":"2017","unstructured":"Sanz-Garcia E, Argiles G, Elez E, Tabernero J. BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives. Ann Oncol. 2017;28(11):2648\u201357. https:\/\/doi.org\/10.1093\/annonc\/mdx401.","journal-title":"Ann Oncol"},{"issue":"4","key":"1372_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1634\/theoncologist.2009-0233","volume":"15","author":"S Tejpar","year":"2010","unstructured":"Tejpar S, Bertagnolli M, Bosman F, et al. Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery. Oncologist. 2010;15(4):390\u2013404. https:\/\/doi.org\/10.1634\/theoncologist.2009-0233.","journal-title":"Oncologist"},{"issue":"3","key":"1372_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1158\/2159-8290.CD-11-0341","volume":"2","author":"RB Corcoran","year":"2012","unstructured":"Corcoran RB, Ebi H, Turke AB, et al. EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib. Cancer Discov. 2012;2(3):227\u201335. https:\/\/doi.org\/10.1158\/2159-8290.CD-11-0341.","journal-title":"Cancer Discov"},{"issue":"44","key":"1372_CR24","doi-asserted-by":"publisher","first-page":"7436","DOI":"10.1038\/sj.onc.1207980","volume":"23","author":"M Frattini","year":"2004","unstructured":"Frattini M, Ferrario C, Bressan P, et al. Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer. Oncogene. 2004;23(44):7436\u201340. https:\/\/doi.org\/10.1038\/sj.onc.1207980.","journal-title":"Oncogene"},{"issue":"6892","key":"1372_CR25","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417(6892):949\u201354. https:\/\/doi.org\/10.1038\/nature00766.","journal-title":"Nature"},{"issue":"1","key":"1372_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.critrevonc.2012.11.003","volume":"87","author":"F Sclafani","year":"2013","unstructured":"Sclafani F, Gullo G, Sheahan K, Crown J. BRAF mutations in melanoma and colorectal cancer: a single oncogenic mutation with different tumour phenotypes and clinical implications. Crit Rev Oncol Hematol. 2013;87(1):55\u201368. https:\/\/doi.org\/10.1016\/j.critrevonc.2012.11.003.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"1372_CR27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41591-022-02181-8","volume":"29","author":"J Tian","year":"2023","unstructured":"Tian J, Chen JH, Chao SX, et al. Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial. Nat Med. 2023;29(2):458\u201366. https:\/\/doi.org\/10.1038\/s41591-022-02181-8.","journal-title":"Nat Med"},{"key":"1372_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.semcancer.2018.05.002","volume":"55","author":"W Wang","year":"2019","unstructured":"Wang W, Kandimalla R, Huang H, et al. Molecular subtyping of colorectal cancer: recent progress, new challenges and emerging opportunities. Semin Cancer Biol. 2019;55:37\u201352. https:\/\/doi.org\/10.1016\/j.semcancer.2018.05.002.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"1372_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2009.01.022","volume":"283","author":"C Montagut","year":"2009","unstructured":"Montagut C, Settleman J. Targeting the RAF-MEK-ERK pathway in cancer therapy. Cancer Lett. 2009;283(2):125\u201334. https:\/\/doi.org\/10.1016\/j.canlet.2009.01.022.","journal-title":"Cancer Lett"},{"issue":"3","key":"1372_CR30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178\u201396. https:\/\/doi.org\/10.1038\/nrm3758.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"1372_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306535","volume":"11","author":"B Li","year":"2024","unstructured":"Li B, Ming H, Qin S, et al. HSPA8 activates Wnt\/\u03b2-catenin signaling to facilitate BRAF V600E colorectal cancer progression by CMA-mediated CAV1 degradation. Adv Sci. 2024;11(3):e2306535. https:\/\/doi.org\/10.1002\/advs.202306535.","journal-title":"Adv Sci"},{"issue":"5","key":"1372_CR32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.14670\/HH-18-079","volume":"34","author":"JY Ng","year":"2019","unstructured":"Ng JY, Lu CT, Lam AK. BRAF mutation: current and future clinical pathological applications in colorectal carcinoma. Histol Histopathol. 2019;34(5):469\u201377. https:\/\/doi.org\/10.14670\/HH-18-079.","journal-title":"Histol Histopathol"},{"issue":"7","key":"1372_CR33","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2018.0996","volume":"153","author":"GA Margonis","year":"2018","unstructured":"Margonis GA, Buettner S, Andreatos N, et al. Association of BRAF mutations with survival and recurrence in surgically treated patients with metastatic colorectal liver cancer. JAMA Surg. 2018;153(7):e180996. https:\/\/doi.org\/10.1001\/jamasurg.2018.0996.","journal-title":"JAMA Surg"},{"issue":"4","key":"1372_CR34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1200\/JCO.20.03043","volume":"39","author":"C Eng","year":"2021","unstructured":"Eng C. BRAF mutation in colorectal cancer: an enigmatic target. J Clin Oncol. 2021;39(4):259\u201361. https:\/\/doi.org\/10.1200\/JCO.20.03043.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1372_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065995","volume":"8","author":"ZX Yuan","year":"2013","unstructured":"Yuan ZX, Wang XY, Qin QY, et al. The prognostic role of BRAF mutation in metastatic colorectal cancer receiving anti-EGFR monoclonal antibodies: a meta- analysis. PLoS ONE. 2013;8(6):e65995. https:\/\/doi.org\/10.1371\/journal.pone.0065995.","journal-title":"PLoS ONE"},{"issue":"4","key":"1372_CR36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrm2147","volume":"8","author":"KH Vousden","year":"2007","unstructured":"Vousden KH, Lane DP. P53 in health and disease. Nat Rev Mol Cell Biol. 2007;8(4):275\u201383. https:\/\/doi.org\/10.1038\/nrm2147.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"1372_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092125","volume":"13","author":"MC Liebl","year":"2021","unstructured":"Liebl MC, Hofmann TG. The role of p53 signaling in colorectal cancer. Cancers. 2021;13(9):2125. https:\/\/doi.org\/10.3390\/cancers13092125.","journal-title":"Cancers"},{"issue":"4","key":"1372_CR38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/jmcb\/mjy075","volume":"11","author":"M Nakayama","year":"2019","unstructured":"Nakayama M, Oshima M. Mutant p53 in colon cancer. J Mol Cell Biol. 2019;11(4):267\u201376. https:\/\/doi.org\/10.1093\/jmcb\/mjy075.","journal-title":"J Mol Cell Biol"},{"issue":"30","key":"1372_CR39","doi-asserted-by":"publisher","first-page":"7518","DOI":"10.1200\/JCO.2005.00.471","volume":"23","author":"A Russo","year":"2005","unstructured":"Russo A, Bazan V, Iacopetta B, et al. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol. 2005;23(30):7518\u201328. https:\/\/doi.org\/10.1200\/JCO.2005.00.471.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1372_CR40","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/path.6392","volume":"265","author":"VK \u00c4ij\u00e4l\u00e4","year":"2025","unstructured":"\u00c4ij\u00e4l\u00e4 VK, H\u00e4rk\u00f6nen J, Mantere T, et al. Comprehensive characterization of micropapillary colorectal adenocarcinoma. J Pathol. 2025;265(4):408\u201321. https:\/\/doi.org\/10.1002\/path.6392.","journal-title":"J Pathol"},{"key":"1372_CR41","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2021.13","volume":"23","author":"L Han","year":"2021","unstructured":"Han L, Wang S, Wei C, et al. Tumour microenvironment: a non-negligible driver for epithelial-mesenchymal transition in colorectal cancer. Expert Rev Mol Med. 2021;23:e16. https:\/\/doi.org\/10.1017\/erm.2021.13.","journal-title":"Expert Rev Mol Med"},{"issue":"7471","key":"1372_CR42","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, McLellan MD, Vandin F, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013;502(7471):333\u20139. https:\/\/doi.org\/10.1038\/nature12634.","journal-title":"Nature"},{"issue":"24","key":"1372_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246206","volume":"13","author":"R Chandra","year":"2021","unstructured":"Chandra R, Karalis JD, Liu C, et al. The colorectal cancer tumor microenvironment and its impact on liver and lung metastasis. Cancers (Basel). 2021;13(24):6206. https:\/\/doi.org\/10.3390\/cancers13246206.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1372_CR44","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s10549-020-05913-x","volume":"184","author":"F Deman","year":"2020","unstructured":"Deman F, Punie K, Laenen A, et al. Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes. Breast Cancer Res Treat. 2020;184(3):985\u201398. https:\/\/doi.org\/10.1007\/s10549-020-05913-x.","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"1372_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103669","volume":"28","author":"M Al Zein","year":"2023","unstructured":"Al Zein M, Boukhdoud M, Shammaa H, et al. Immunotherapy and immunoevasion of colorectal cancer. Drug Discov Today. 2023;28(9):103669. https:\/\/doi.org\/10.1016\/j.drudis.2023.103669.","journal-title":"Drug Discov Today"},{"issue":"1","key":"1372_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","volume":"52","author":"PS Hegde","year":"2020","unstructured":"Hegde PS, Chen DS. Top 10 challenges in cancer immunotherapy. Immunity. 2020;52(1):17\u201335. https:\/\/doi.org\/10.1016\/j.immuni.2019.12.011.","journal-title":"Immunity"},{"issue":"6","key":"1372_CR47","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1053\/j.gastro.2021.09.059","volume":"161","author":"D Wang","year":"2021","unstructured":"Wang D, Cabalag CS, Clemons NJ, DuBois RN. Cyclooxygenases and prostaglandins in tumor immunology and microenvironment of gastrointestinal cancer. Gastroenterology. 2021;161(6):1813\u201329. https:\/\/doi.org\/10.1053\/j.gastro.2021.09.059.","journal-title":"Gastroenterology"},{"issue":"2","key":"1372_CR48","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12307-010-0052-5","volume":"4","author":"M Erreni","year":"2011","unstructured":"Erreni M, Mantovani A, Allavena P. Tumor-associated macrophages (TAM) and inflammation in colorectal cancer. Cancer Microenviron. 2011;4(2):141\u201354. https:\/\/doi.org\/10.1007\/s12307-010-0052-5.","journal-title":"Cancer Microenviron"},{"issue":"5","key":"1372_CR49","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41568-021-00332-6","volume":"21","author":"AW Lambert","year":"2021","unstructured":"Lambert AW, Weinberg RA. Linking EMT programs to normal and neoplastic epithelial stem cells. Nat Rev Cancer. 2021;21(5):325\u201338. https:\/\/doi.org\/10.1038\/s41568-021-00332-6.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1372_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52816-z","volume":"9","author":"T Ieda","year":"2019","unstructured":"Ieda T, Tazawa H, Okabayashi H, et al. Visualization of epithelial-mesenchymal transition in an inflammatory microenvironment-colorectal cancer network. Sci Rep. 2019;9(1):16378. https:\/\/doi.org\/10.1038\/s41598-019-52816-z.","journal-title":"Sci Rep"},{"issue":"1","key":"1372_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1019-x","volume":"18","author":"JL Hu","year":"2019","unstructured":"Hu JL, Wang W, Lan XL, et al. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial- mesenchymal transition in colorectal cancer. Mol Cancer. 2019;18(1):91. https:\/\/doi.org\/10.1186\/s12943-019-1019-x.","journal-title":"Mol Cancer"},{"issue":"4","key":"1372_CR52","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00109-013-1020-6","volume":"91","author":"C Kahlert","year":"2013","unstructured":"Kahlert C, Kalluri R. Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berlin). 2013;91(4):431\u20137. https:\/\/doi.org\/10.1007\/s00109-013-1020-6.","journal-title":"J Mol Med (Berlin)"},{"issue":"12","key":"1372_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126262","volume":"22","author":"M Nenkov","year":"2021","unstructured":"Nenkov M, Ma Y, Ga\u00dfler N, Chen Y. Metabolic reprogramming of colorectal cancer cells and the microenvironment: implication for therapy. Int J Mol Sci. 2021;22(12):6262. https:\/\/doi.org\/10.3390\/ijms22126262.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1372_CR54","doi-asserted-by":"publisher","first-page":"817","DOI":"10.7150\/jca.14274","volume":"7","author":"S Devic","year":"2016","unstructured":"Devic S. Warburg effect - a consequence or the cause of carcinogenesis? J Cancer. 2016;7(7):817\u201322. https:\/\/doi.org\/10.7150\/jca.14274.","journal-title":"J Cancer"},{"issue":"1","key":"1372_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23(1):27\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006.","journal-title":"Cell Metab"},{"key":"1372_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1089918","volume":"13","author":"Q Sun","year":"2023","unstructured":"Sun Q, Wu J, Zhu G, et al. Lactate-related metabolic reprogramming and immune regulation in colorectal cancer. Front Endocrinol (Lausanne). 2023;13:1089918. https:\/\/doi.org\/10.3389\/fendo.2022.1089918.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1372_CR57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jcb.30347","volume":"124","author":"D Chen","year":"2023","unstructured":"Chen D, Zhou X, Yan P, et al. Lipid metabolism reprogramming in colorectal cancer. J Cell Biochem. 2023;124(1):3\u201316. https:\/\/doi.org\/10.1002\/jcb.30347.","journal-title":"J Cell Biochem"},{"issue":"7","key":"1372_CR58","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","volume":"20","author":"CC Wong","year":"2023","unstructured":"Wong CC, Yu J. Gut microbiota in colorectal cancer development and therapy. Nat Rev Clin Oncol. 2023;20(7):429\u201352. https:\/\/doi.org\/10.1038\/s41571-023-00766-x.","journal-title":"Nat Rev Clin Oncol"},{"issue":"30","key":"1372_CR59","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.3748\/wjg.v28.i30.4053","volume":"28","author":"AEV Quaglio","year":"2022","unstructured":"Quaglio AEV, Grillo TG, De Oliveira ECS, Di Stasi LC, Sassaki LY. Gut microbiota, inflammatory bowel disease and colorectal cancer. World J Gastroenterol. 2022;28(30):4053\u201360. https:\/\/doi.org\/10.3748\/wjg.v28.i30.4053.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"1372_CR60","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1753-4887.1998.tb01765.x","volume":"56","author":"YI Kim","year":"1998","unstructured":"Kim YI. Diet, lifestyle, and colorectal cancer: is hyperinsulinemia the missing link? Nutr Rev. 1998;56(9):275\u20139. https:\/\/doi.org\/10.1111\/j.1753-4887.1998.tb01765.x.","journal-title":"Nutr Rev"},{"issue":"6","key":"1372_CR61","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2217\/fon-2017-0578","volume":"14","author":"S Karunanithi","year":"2018","unstructured":"Karunanithi S, Levi L. High-fat diet and colorectal cancer: myths and facts. Future Oncol. 2018;14(6):493\u20135. https:\/\/doi.org\/10.2217\/fon-2017-0578.","journal-title":"Future Oncol"},{"issue":"7","key":"1372_CR62","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","volume":"183","author":"AE Ringel","year":"2020","unstructured":"Ringel AE, Drijvers JM, Baker GJ, et al. Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity. Cell. 2020;183(7):1848-1866.e26. https:\/\/doi.org\/10.1016\/j.cell.2020.11.009.","journal-title":"Cell"},{"issue":"8","key":"1372_CR63","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S1470-2045(21)00343-0","volume":"22","author":"N Zhang","year":"2021","unstructured":"Zhang N, Ng AS, Cai S, Li Q, Yang L, Kerr D. Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer. Lancet Oncol. 2021;22(8):e358\u201368. https:\/\/doi.org\/10.1016\/S1470-2045(21)00343-0.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1372_CR64","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41556-018-0196-y","volume":"21","author":"MP Stemmler","year":"2019","unstructured":"Stemmler MP, Eccles RL, Brabletz S, Brabletz T. Non-redundant functions of EMT transcription factors. Nat Cell Biol. 2019;21(1):102\u201312. https:\/\/doi.org\/10.1038\/s41556-018-0196-y.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"1372_CR65","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/his.13068","volume":"70","author":"RS Gonzalez","year":"2017","unstructured":"Gonzalez RS, Huh WJ, Cates JM, et al. Micropapillary colorectal carcinoma: clinical, pathological and molecular properties, including evidence of epithelial-mesenchymal transition. Histopathology. 2017;70(2):223\u201331. https:\/\/doi.org\/10.1111\/his.13068.","journal-title":"Histopathology"},{"issue":"3","key":"1372_CR66","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1309\/AJCPFEA7KA0SBBNA","volume":"142","author":"V Barresi","year":"2014","unstructured":"Barresi V, Branca G, Vitarelli E, Tuccari G. Micropapillary pattern and poorly differentiated clusters represent the same biological phenomenon in colorectal cancer: a proposal for a change in terminology. Am J Clin Pathol. 2014;142(3):375\u201383. https:\/\/doi.org\/10.1309\/AJCPFEA7KA0SBBNA.","journal-title":"Am J Clin Pathol"},{"issue":"17","key":"1372_CR67","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1242\/jcs.099655","volume":"125","author":"RL Haines","year":"2012","unstructured":"Haines RL, Lane EB. Keratins and disease at a glance. J Cell Sci. 2012;125(17):3923\u20138. https:\/\/doi.org\/10.1242\/jcs.099655.","journal-title":"J Cell Sci"},{"issue":"10","key":"1372_CR68","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.yexcr.2007.03.005","volume":"313","author":"TM Magin","year":"2007","unstructured":"Magin TM, Vijayaraj P, Leube RE. Structural and regulatory functions of keratins. Exp Cell Res. 2007;313(10):2021\u201332. https:\/\/doi.org\/10.1016\/j.yexcr.2007.03.005.","journal-title":"Exp Cell Res"},{"key":"1372_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102643","volume":"121","author":"J Badia-Ramentol","year":"2023","unstructured":"Badia-Ramentol J, Gimeno-Valiente F, Dur\u00e9ndez E, et al. The prognostic potential of CDX2 in colorectal cancer: harmonizing biology and clinical practice. Cancer Treat Rev. 2023;121:102643. https:\/\/doi.org\/10.1016\/j.ctrv.2023.102643.","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"1372_CR70","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3748\/wjg.v21.i5.1457","volume":"21","author":"JM Bae","year":"2015","unstructured":"Bae JM, Lee TH, Cho NY, Kim TY, Kang GH. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients. World J Gastroenterol. 2015;21(5):1457\u201367. https:\/\/doi.org\/10.3748\/wjg.v21.i5.1457.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1372_CR71","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/modpathol.2011.1","volume":"24","author":"M Verd\u00fa","year":"2011","unstructured":"Verd\u00fa M, Rom\u00e1n R, Calvo M, et al. Clinicopathological and molecular characterization of colorectal micropapillary carcinoma. Mod Pathol. 2011;24(5):729\u201338. https:\/\/doi.org\/10.1038\/modpathol.2011.1.","journal-title":"Mod Pathol"},{"issue":"3","key":"1372_CR72","first-page":"183","volume":"59","author":"T Kondo","year":"2008","unstructured":"Kondo T. Colon invasive micropapillary carcinoma arising in tubulovillous adenoma. Pol J Pathol. 2008;59(3):183\u20135.","journal-title":"Pol J Pathol"},{"issue":"7","key":"1372_CR73","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/modpathol.3800790","volume":"20","author":"B Haupt","year":"2007","unstructured":"Haupt B, Ro JY, Schwartz MR, Shen SS. Colorectal adenocarcinoma with micropapillary pattern and its association with lymph node metastasis. Mod Pathol. 2007;20(7):729\u201333. https:\/\/doi.org\/10.1038\/modpathol.3800790.","journal-title":"Mod Pathol"},{"issue":"9","key":"1372_CR74","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1097\/PAS.0b013e3181a5387b","volume":"33","author":"F Xu","year":"2009","unstructured":"Xu F, Xu J, Lou Z, et al. Micropapillary component in colorectal carcinoma is associated with lymph node metastasis in T1 and T2 stages and decreased survival time in TNM stages I and II. Am J Surg Pathol. 2009;33(9):1287\u201392. https:\/\/doi.org\/10.1097\/PAS.0b013e3181a5387b.","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"1372_CR75","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/jjco\/hyp051","volume":"39","author":"H Sonoo","year":"2009","unstructured":"Sonoo H, Kameyama M, Inatugi N, Nonomura A, Enomoto Y. Pedunculated polyp of early sigmoid colon cancer with invasive micropapillary carcinoma. Jpn J Clin Oncol. 2009;39(8):523\u20137. https:\/\/doi.org\/10.1093\/jjco\/hyp051.","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"1372_CR76","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3892\/ol.2016.4717","volume":"12","author":"K Jakubowska","year":"2016","unstructured":"Jakubowska K, Guzi\u0144ska-Ustymowicz K, Pryczynicz A. Invasive micropapillary component and its clinico-histopathological significance in patients with colorectal cancer. Oncol Lett. 2016;12(2):1154\u20138. https:\/\/doi.org\/10.3892\/ol.2016.4717.","journal-title":"Oncol Lett"},{"issue":"5","key":"1372_CR77","first-page":"432","volume":"147","author":"LS Lino-Silva","year":"2011","unstructured":"Lino-Silva LS, Salcedo-Hern\u00e1ndez RA. Carcinoma rectal micropapilar. un caso inusual [A rare case of colorectal micropapillary carcinoma]. Gac Med Mex. 2011;147(5):432\u20136.","journal-title":"Gac Med Mex"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01372-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01372-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01372-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:02:48Z","timestamp":1773784968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01372-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1372"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01372-z","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"7 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable-no newdata generated. Data sharing is not applicable to this article as no new data were created oranalyzed in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Sharing"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}